Abstract
Purpose
Rectal neuroendocrine tumours (NETs) often present as an incidental finding during colonoscopy. Complete endoscopic resection of low-grade NETs up to 10 mm is considered safe. Whether this is also safe for NETs up to 20 mm is unclear. We performed a nationwide study to determine the risk of lymph node and distant metastases in endoscopically removed NETs.
Methods
All endoscopically removed rectal NETs between 1990 and 2010 were identified using the national pathology database (PALGA). Each NET was stratified according to size, grade and resection margin. Follow-up was until February 2016.
Results
Between 1990 and 2010, a total of 310 NETs smaller than 20 mm were endoscopically removed. Mean size of NETs was 7.4 mm (SD 3.5). In 49% of NETs (n = 153), no grade (G) could be assessed from the pathology report, 1% was G2 (n = 3), and the remaining NETs were G1. Median follow up was 11.6 years (range 4.9–26.0). During follow-up, 30 patients underwent surgical resection. Lymph node or distant metastasis was seen in 3 patients (1%) which all had a grade 2 NET. Mean time from endoscopic resection to diagnosis of metastases was 6.1 years (95% CI 2.9–9.2).
Conclusion
No lymph node or distant metastases were seen in endoscopically removed G1 NETs up to 20 mm during the long follow-up of this nationwide study. This adds evidence to the ENET guideline that endoscopic resection of G1 NETs up to 20 mm appears to be safe.
Similar content being viewed by others
References
Vassiliki LT, Wertheim B, Guerrero MA et al (2012) Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis. J Cancer 3:292–302
Scherübl H (2009) Rectal carcinoids are on the rise: early detection by screening endoscopy. Endoscopy. 41(2):162–165
Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 97(4):934–959
Suk Jung Y, Yun KE, Chang Y et al Risk factors associated with rectal neuroendocrine tumors: a cross-sectional study. Cancer Epidemiol Biomark Prev 23(7):1406–1413
Kooyker AI, Verbeek WHM, Van den Berg JG, Tesselaar MET, Van Leerdam ME (2020) Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade. United European Gastroenterol J 8(1):59–67
Le Clercq C, Bouwens M and Riedl R et al Macroscopic features of neuroendocrine colorectal cancers: a 10-year retrospective study. Abstract AGA 2012 Tu1163
Ramage JK, De Herder WW, Delle Fave G et al (2016) ENETS consensus guidelines update for colorectal neuroendocrine neoplasms. Neuroendocrinology 103:139–143
Kulke MH, Shah MH, Benson AB et al (2015) Neuroendocrine tumors, version 1.2015. J Natl Compr Cancer Netw 13(1):78–108
Anthony LB, Strosberg JR, Klimstra DS, Maples WJ, O'Dorisio TM, Warner RR, Wiseman GA, Benson AB 3rd, Pommier RF, North American Neuroendocrine Tumor Society (NANETS) (2010) The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum. Pancreas. 39(6):767–774
Gleeson FC, Levy MJ, Dozois EJ, Larson DW, Kee Song LMW, Boardman LA (2014) Endoscopically identified well-differentiated rectal carcinoid tumors: impact of tumor size on the natural history and outcomes. Gastrointest Endosc 80(1):144–151
Kojima M, Ikeda K, Saito N et al (2016) Neuroendocrine tumors of the large intestine: clinicopathological features and predictive factors of lymph node metastasis. Front Oncol 6:173
Kasuga A, Chino A, Uragami N, Kishihara T, Igarashi M, Fujita R, Yamamoto N, Ueno M, Oya M, Muto T (2012) Treatment strategy for rectal carcinoids: a clinicopathological analysis of 229 cases at a single cancer institution. J Gastroenterol Hepatol 27(12):1801–1807
Casparie M, Tiebosch AT, Burger G, Blauwgeers H, Van de Pol H, Van Krieken JHJM, Meijer GA (2007) Pathology databanking and biobanking in the Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29:19–24
Kaneko H, Hirasawa K, Koh R, Kobayashi R, Kokawa A, Tanaka K, Maeda S (2016) Treatment outcomes of endoscopic resection for rectal carcinoid tumors: an analysis of the resectability and long-term results from 46 consecutive cases. Scand J Gastroenterol 51(12):1489–1494
Kim J, Kim JH, Lee JY, Chun J, Im JP, Sung Kim J (2018) Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor. BMC Gastroenterol 18(1):77
Kwaan MR, Goldberg JE, Bleday R (2008) Rectal carcinoid tumors: review of results after endoscopic and surgical therapy. Arch Surg 143(5):471
Shirouzu K, Isomoto H, Kakegawa T, Morimatsu M (1990) Treatment of rectal carcinoid tumors. Am J Surg 160(3):262–265
Landry CS, Brock G, Scoggins CR, McMasters KM, Martin RCG 2nd (2008) Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients. J Am Coll Surg 207(6):874–881
Shields CJ, Tiret E, Winter DC (2010) International Rectal Carcinoid Study Group. Carcinoid tumors of the rectum: a multi-institutional international collaboration. Ann Surg 252(5):750–755
Anderson BW, Smyrk TC, Anderson KS, Mahoney DW, Devens ME, Sweetser SR, Kisiel JB, Ahlquist DA (2016) Endoscopic overestimation of colorectal polyp size. Gastrointest Endosc 83(1):201–208
Weinstock BA, Ward SCB, Harpaz NB, Warner RRP, Itzkowitz S, Kang Kim M (2013) Clinical and prognostic features of rectal neuroendocrine tumors. Neuroendocrinology 98:180–187
Al Natour RH, Saund MS, Sanchez VM et al (2012) Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection. J Gastrointest Surg 16(3):595–602
Soga J (2005) Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer. 103(8):1587–1595 Review
Fahy BN, Tang LH, Klimstra D et al (2006) Carcinoid of the Rectum Risk Stratification (CaRRs): A Strategy for Preoperative Outcome Assessment. Ann Surg Oncol 14(5):1735–1743
Ngamruengphong S, Kamal A, Akshintala V, Hajiyeva G, Hanada Y, Chen YI, Sanaei O, Fluxa D, Haito Chavez Y, Kumbhari V, Singh VK, Lennon AM, Canto MI, Khashab MA (2019) Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors. Gastrointest Endosc 89(3):602–606
Zhao B, Hollandsworth HM, Lopez NE, Parry LA, Abbadessa B, Cosman BC, Ramamoorthy SL, Eisenstein S (2020) Outcomes for a large cohort of patients with rectal neuroendocrine tumors: an analysis of the national cancer database. J Gastrointest Surg. https://doi.org/10.1007/s11605-020-04525-6
Konishi T, Watanabe T, Kishimoto J et al (2007) Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut 56(6):86
Author information
Authors and Affiliations
Contributions
T Kuiper: Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript
M G H van Oijen: Study concept and design; analysis and interpretation of data; statistical analysis; critical revision of the manuscript
M F van Velthuysen: Analysis and interpretation of data; critical revision of the manuscript
N van Lelyveld: Critical revision of the manuscript
M E van Leerdam: Analysis and interpretation of data; critical revision of the manuscript
F D Vleggaar: Critical revision of the manuscript
H J Klümpen: Study concept and design; critical revision of the manuscript
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kuiper, T., van Oijen, M.G.H., van Velthuysen, M.F. et al. Endoscopically removed rectal NETs: a nationwide cohort study. Int J Colorectal Dis 36, 535–541 (2021). https://doi.org/10.1007/s00384-020-03801-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-020-03801-w